with their unconditional contributions
01 August 2015 : Last day for early registration
05 August 2015 : Abstract Submission Deadline
14-18 October 2015 : Date of congress
SCIENTIFIC
PROGRAM
Please click on the topics to watch the presentations.
|
14 October 2015 Opening Session Dolmabahce Ballroom |
||
|
16:00-16:15 |
Suleyman Dincer |
|
|
Moderators: Giuseppe Saglio, Birol Guvenc |
||
|
16:15-16:45 |
European Leukemia Net Recommendations for Chronic Myeloid Leukemia |
Rudiger Hehlmann |
|
16:45-17:15 |
Iron overload in MDS and in stem cell transplantation - Is There a Rationale for Treatment? |
Eliezer Rachmilewitz |
|
17:15-17:45 |
Chimeric Antigen Receptor-Engineered T-Cell
|
Saar Gill |
|
17:45 |
Welcome Cocktail |
|
|
15 October 2015 Dolmabahce Ballroom |
||||
|
Acute Leukemias Moderators: Ali Unal, Sevgi Kalayoglu Besisik |
||||
|
08:30-09:00 |
Acute Lymphocytic Leukemia Current and Future Therapeutic Strategies |
Dieter Hoelzer |
||
|
09:00-09:30 |
Diagnostic and Prognostic Markers in Acute Lymphoblastic Leukemia |
Monica Messina |
||
|
09:30-10:00 |
Debate: In Ph-Positive Acute Lymphoblastic Leukemia, Do We Need Chemo in Induction Therapy? |
Josè Maria Ribera |
||
|
10:00-10:15 |
Coffee Break and Discussion with the Speakers |
|||
|
Acute Leukemias Moderators: Cengiz Beyan, Tulin Tuglular |
||||
|
10:15-10:45 |
Acute Myeloid Leukemia Current and Future Therapeutic Strategies |
Alan Burnett |
||
|
10:45-11:15 |
Acute Leukemias in the Elderly |
Charles Schiffer |
||
|
11.15 |
Lunch Break |
|||
|
Chronic Leukemias Moderators: Guray Saydam, Mehmet Turgut |
||||
|
13:00-13:30 |
Chronic Myeloid Leukemia Treatment strategies |
Hagop Kantarjian |
||
|
13:30-14:00 |
Essential Response monitoring in Chronic Myeloid Leukemia |
Naeem Chaudhri |
||
|
14:00-14:30 |
Treatment Discontinuation in Chronic Myeloid Leukemia When and How |
Giuseppe Saglio |
||
|
14:30-15:00 |
Chronic Lymphocytic Leukemia
|
Hagop Kantarjian |
||
|
15:00-15:15 |
Coffee Break and Discussion with the Speakers |
|||
|
CLL Moderators:Nilgun Sayinalp, Ferit Avcu |
||||
|
15:15-15:45 |
Chronic Lymphocytic Leukemia
|
Paolo Ghia |
||
|
15:45-16:15 |
Myeloproliferative Neoplasms Current Treatment of Myeloproliferative Neoplasms |
Petro Petrides |
||
|
16:15-16:45 |
JAK2 Inhibitors in Myeloproliferative Disorders |
Daniela Cilloni |
||
|
16:45-17:15 |
New Drugs for Myeloproliferative Disorders |
Tariq Mughal |
||
|
Special Session: Genomics in Hematological Malignancies |
||||
|
17:15-17:30 |
Comprehensive Genomic Profiling in Acute Myeloid Leukemia |
Farhad Ravandi Kashani |
||
|
17:30-17:45 |
Integrating NGS in Suboptimal Responders with Chronic Myeloid Leukemia |
Giuseppe Saglio |
||
|
17:45-18:00 |
Molecular Profiling to Improve Clinical Management of Patients with Lymphomas |
Carmino De Souza |
||
|
18:00-18:15 |
Clinical Utility of Next Generation Sequencing for Optimal Management and Minimal Residual Disease Assessment in Myeloma |
Evangelos Terpos |
||
|
16 October 2015 Dolmabahce Ballroom |
||||
|
Lymphomas and Myeloma-1 Moderators: Rauf Haznedar, Mustafa Solak |
||||
|
08:30-09:00 |
Targeting CD30 in Hematological Malignancies: The Example of Hodgkin Lymphoma |
Hanan Hamed |
||
|
09:00-09:30 |
Multiple Myeloma Therapy |
Evangelos Terpos |
||
|
09:30-10:00 |
Monoclonal Gammopathies of Undetermined Significance and Smoldering Multiple Myeloma: Predictors of Progression and
|
Hande Hayırlıoglu Tuncer |
||
|
10:00-10:15 |
Coffee Break and Discussion with the Speakers |
|||
|
Lymphomas and Myeloma-2 Moderators: Oral Nevruz, Sehmuz Ertop |
||||
|
10:15-10:45 |
Hairy Cell Leukemia |
Farhad Ravandi Kashani |
||
|
10:45-11:15 |
Diffuse Large B-Cell Lymphoma
|
Carmino De Souza |
||
|
11:15-11:45 |
|
Khaled Halahleh |
||
|
11:45-12:15 |
Indolent Lymphomas: Practical Clinical Approach |
Berksoy Sahin |
||
|
12:15 |
Lunch Break |
|||
|
Thalassemias, Hemaglobinopaties and Iron Overload Moderators: Nejat Akar, Gulyuz Ozturk |
||||
|
13:00-13.30 |
Management of Sickle Cell Disease |
Salam Al-Kindi |
||
|
13.30-14:00 |
IOL Pathogenesis and Clinical Outcomes |
Daniela Cilloni |
||
|
14:00-14:15 |
Coffee Break and Discussion with the Speakers |
|||
|
Anticoagulants & Antibiotic Therapy Moderators: Deniz Sargin, Sema Anak |
||||
|
15:15-15:45 |
Antibiotic Strategy in Neutropenia |
Omrum Uzun |
||
|
14:45-15:15 |
Invasive Fungal Infection Management |
Samir Agrawal |
||
|
14:15-14:45 |
Thrombophilia screening in 2015. Which patients, which tests |
Pierre Toulon |
||
|
16 October 2015 Meet the experts on ITP Dolmabahce Ballroom A |
||
|
|
||
|
11:30-12:30 |
Breaking Barriers and Extending Experience with Revolade |
Tulin Tuglular |
|
17 October 2015 Dolmabahce Ballroom |
|||
|
Stem Cell Transplant-1 Moderators: Evren Ozdemir, Seckin Cagirgan |
|||
|
08:30-09:00 |
Stem Cell Biology |
Albert Donnenberg |
|
|
09:00-09:30 |
Stem Cell Transplantation. Cord Blood or Haploidentical Transplant for Adults Without a Suitable Donor? 00 |
Daniela Cilloni |
|
|
09:30-10:00 |
Engineered T-Cell treatment In The Area For Acute Lymphoblastic Leukemia |
Francesco Saglio |
|
|
10:00-10:15 |
Coffee Break and Discussion with the Speakers |
||
|
Anemias Moderators: Salih Aksu, Jelena Roganovic |
|||
|
10:15-10:45 |
Clinical Findings and Diagnosis of Fanconi Anemia |
Sule Unal |
|
|
10:45-11:15 |
Hematopoietic Stem Cell Transplantation in Fanconi Anemia |
Fatma Visal Okur |
|
|
11:15-11:45 |
Congenital Dyserytropoietic Anemia |
Achille Iolascon |
|
|
11:45-12:15 |
Schwachman-Diamond Syndrome |
Akiko Shimamura |
|
|
12:15 |
Lunch Break |
||
|
Myelodysplastic Syndrome Moderators: Ridvan Ali, Aysen Timuragaoglu |
|||
|
13:00-13:30 |
How many and Which Molecular Markers Are Really Needed in the Management of Acute Leukemias and MDS? |
Mehmet Yilmaz |
|
|
13:30-14:00 |
Myelodysplastic Syndrome: Biology and Classification |
Guillermo Garcia Manero |
|
|
14:00-14:30 |
Myelodysplastic Syndrome Therapy Old and New Aspects |
Elias Jabbour |
|
|
14:30-14:45 |
Coffee Break and Discussion with the Speakers |
||
|
Stem Cell Transplant-2 Moderators: Osman Ozcebe, Duzgun Ozatli |
|||
|
14:45-15:15 |
Stem Cell Mobilization for Autologous Transplant. Ways to Improve the Collection and to Prevent the Failure. |
Albert Donnenberg |
|
|
15:15- 16:00 |
Debate:Allogeneic HSCT for Standard Risk ALL in CR1 |
No: Said Yousuf Ahmed
|
|
|
16:00-16:30 |
Invasive Fungal Infections in Immunocompromised Patients: Diagnosis and Management According to International Guidelines |
Livio Pagano |
|
|
16:30-17:00 |
Rational Drug Use and Pharmaceutical Industry |
Canan Uluoglu |
|
|
17 October 2015 Meet the experts on coagulation disorders Dolmabahce Ballroom |
||
|
Moderators: Fahri Sahin, Bulent Zulfikar |
||
|
17:00-17:30 |
Innovations in the Treatment of Hemophilia |
Bulent Antmen |
|
17:30-18:00 |
Diagnosis and Management of Peri-Operative Bleeding and Thrombosis Risk |
Burak Uz |
|
17 October 2015 Poster Discussion Dolmabahce Ballroom |
||
|
Moderators: Mehmet Dagli, Filiz Vural |
||
|
18:00-18:20 |
Dysregulation of Sheltering Factors Coupled with Telomere Shortening in Philadelphia Chromosome Negative Myeloproliferative Neoplasms |
Jenny Elisabeth Dahlström |
|
18:20-18:40 |
The Importance of High Platelet-Lymphocyte ratio on Prognosis, Duration of Hospitalisation and Development of Hospital Infection Among Intensive Care Patient |
Ali Kutlucan |
|
18:40-19:00 |
The Factors Affecting Early Death After The Initial Therapy of Acute Myeloid Leukemia |
Umit Yavuz Malkan |
|
|
Closing |
|
" * " will be announced later after the offical response.
